You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 51 - 60 of 7898 results
  1. MiDiario: Mobile Intervention for Diabetes via Reflection and Introspection in My Own Words

    SBC: KAIROS RESEARCH LLC            Topic: NIMHD

    PROJECT SUMMARY/ABSTRACT Latino adolescents with Type 1 Diabetes (T1D) face substantial disparities in care and outcomes, making new tools to support this population essential. Managing T1D requires a complex set of knowledge and decision- making skills. Adolescents have specific challenges to managing T1D, including psychosocial needs for autonomy and fitting in with peers, along with still-devel ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  2. Accelerating Gene Therapy and Editing with Advanced MS-Based Data Analysis for Nonstandard and Hybrid Nucleotide Sequences

    SBC: MASSMATRIX INC            Topic: 400

    PROJECT SUMMARY / ABSTRACT Title: Accelerating Gene Therapy and Editing with Advanced MS-Based Data Analysis for Nonstandard and Hybrid Nucleotide Sequences This project seeks to improve reliability and speed up the development of life-saving and life-enhancing oligonucleotide-based therapeutics and magnify the positive impact of biomedical research and education worldwide, leading to a quantum le ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  3. Gene-edited liver organoids for predictive hepatotoxicity

    SBC: Bioprinting Laboratories Inc.            Topic: R

    Project Summary/Abstract Unexpected adverse drug responses (ADRs) including drug-induced liver injury (DILI) are the 4th leading cause of death in the U.S. In addition, DILI in individuals is one of the major reasons for drug withdrawal from the market and is difficult to predict using conventional in vitro hepatotoxicity tests and preclinical animal models. Due to the critical link between DILI a ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  4. Rho GTPase inhibitor for refrigerated platelet storage

    SBC: OGB4 INC            Topic: NHLBI

    SUMMARY The use of platelet transfusions has increased dramatically since 1980s, but a safe, long-term platelet storage method remains missing. Current practice has platelets stored at 20 to 24°C after preparation, which has a limited lifetime up to 5 days primarily due to concerns about bacterial contamination, because cold storage of platelets results in complex molecular lesions that are recog ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  5. Development of An Innovative TEE Technology for Mutation Detection

    SBC: GLC Biotechnology, Inc.            Topic: 102

    AbstractThe objective of this project is to further develop a breakthrough Toehold-Enrichment- Extraction (TEE) technology and validate TEE-based tests for use in cancer detection and care management. TEE is a novel DNA extraction method. Unlike conventional extraction methods, TEE extracts mutated DNA while enriching it with high recovery. Moreover, unlike current PCR- based enrichment methods, T ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  6. Development of peptide drug conjugates for cancer therapy

    SBC: MOLECULAR THERANOSTICS, LLC            Topic: 102

    AbstractThe ultimate goal of this project is to develop and commercialize peptide drug conjugates to treat life- threatening triple negative breast cancer. Triple negative breast cancer (TNBC) is a high aggressive subtype of breast cancer with poor survival. TNBC patients do not respond well to currently available clinical therapies, including targeted therapy. Chemotherapy is commonly used to tre ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  7. Validation of the Genetically Malleable Oncopig Hepatocellular carcinoma (HCC) Model for Targeted Therapeutic Development

    SBC: SUS CLINICALS INC            Topic: 102

    PROJECT ABSTRACT: The goal of this Phase II SBIR proposal is to further validate the genetically defined Oncopig hepatocellular carcinoma (HCC) model—capable of modeling diverse HCC driver mutational profiles through induced KRASG12D and TP53R167H expression and subsequent CRISPR editing—for preclinical evaluation of locally delivered, personalized HCC therapies. HCC is an aggressive liver mal ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  8. CollaLink: Guided-regenerative Scaffold for Augmentation of Anterior Cruciate Ligament Repair

    SBC: COLLAMEDIX INC            Topic: NIAMS

    Summary Tears of the anterior cruciate ligament (ACL) lead to instability of the knee and reduce mobility. An estimated 225,000 ACL tears are reported annually in the US, equating to ~$7B in medical costs. The preferred treatment is reconstruction of the patient’s ACL with an autograft or allograft, which can cause donor site morbidity or immunological response, and have an increased risk of chr ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  9. Development of a novel visualization, labeling, communication and tracking engine for human anatomy.

    SBC: AM OPERATING LLC            Topic: 102

    The key to tracking, collating, and communicating skin cancer data is standardization, enhanced precision, and categorization of anatomic descriptions. Imprecise and non-standardized labeling of anatomic sites for skin cancer biopsies creates challenges in communicating and identifying the skin cancer location at the time of treatment. Diagnostic biopsies often remove the visible cancer cells, and ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  10. OsTend: A load-bearing, bi-phasic collagen scaffold for massive rotator cuff repairs

    SBC: COLLAMEDIX INC            Topic: NIAMS

    1 Summary:2 There are ~300,000 rotator cuff (RC) repair procedures performed in the US annually at an estimated cost of3 $4B. Advanced degeneration of the RC causes pain and major disability. ‘Massive’ or ‘Irreparable’ (rt 5 cm) tears4 of RC consist of detachment between bone and tendon, and degeneration of tendon; thus, they cannot be repaired5 arthroscopically. Representing 40% of RC tea ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government